HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMERICAN CAPITAL MANAGEMENT INC | 736,870 | $31,044,000 | 3.85% |
| Black Creek Investment Management Inc. | 555,577 | $23,406,000 | 2.75% |
| SNYDER CAPITAL MANAGEMENT L P | 1,294,884 | $54,553,000 | 2.68% |
| KESTREL INVESTMENT MANAGEMENT CORP | 452,400 | $19,060,000 | 2.34% |
| Van Berkom & Associates Inc. | 907,795 | $38,245,000 | 2.14% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 2,059,363 | $86,761,000 | 1.45% |
| Champlain Investment Partners, LLC | 1,288,230 | $54,273,000 | 0.96% |
| HERMES INVESTMENT MANAGEMENT LTD | 734,973 | $30,964,000 | 0.94% |
| Netols Asset Management, Inc. | 146,621 | $6,177,000 | 0.94% |
| ANCHOR CAPITAL ADVISORS LLC | 1,112,360 | $46,864,000 | 0.93% |